Accretion Nutraveda Limited (BOM:544694)
India flag India · Delayed Price · Currency is INR
283.00
+11.30 (4.16%)
At close: May 8, 2026

Accretion Nutraveda Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
336.03160.0250.0529.035.85
Other Revenue
1.120.480.641-
337.16160.4950.6930.035.85
Revenue Growth (YoY)
110.07%216.62%68.81%413.23%-
Cost of Revenue
241.04106.0128.9317.343.51
Gross Profit
96.1154.4821.7612.692.34
Selling, General & Admin
10.686.214.22.741.13
Other Operating Expenses
15.3810.534.12.451.39
Operating Expenses
28.6619.1510.928.34.25
Operating Income
67.4535.3310.854.39-1.91
Interest Expense
-5.34-2.78-2.22-1.61-0.81
Interest & Investment Income
-0.020.690.40.01
Currency Exchange Gain (Loss)
-0.01---
Other Non Operating Income (Expenses)
0-0.77-0.18-0.3-0.98
Pretax Income
62.1131.819.152.87-3.69
Income Tax Expense
11.435.680.930.070.15
Net Income
50.6826.138.222.81-3.84
Net Income to Common
50.6826.138.222.81-3.84
Net Income Growth
93.98%217.90%192.91%--
Shares Outstanding (Basic)
5444359
Shares Outstanding (Diluted)
5444359
Shares Change (YoY)
49.16%0.94%--99.00%-
EPS (Basic)
9.357.192.280.78-0.01
EPS (Diluted)
9.357.192.280.78-0.01
EPS Growth
30.04%215.34%192.52%--
Free Cash Flow
-240.09-30.850.726.76-
Free Cash Flow Per Share
-44.29-8.490.201.88-
Gross Margin
28.51%33.95%42.94%42.25%40.05%
Operating Margin
20.01%22.02%21.40%14.60%-32.61%
Profit Margin
15.03%16.28%16.21%9.35%-65.65%
Free Cash Flow Margin
-71.21%-19.22%1.42%22.51%-
EBITDA
70.0637.7513.467.5-0.17
EBITDA Margin
20.78%23.52%26.56%24.97%-2.97%
D&A For EBITDA
2.62.412.623.111.73
EBIT
67.4535.3310.854.39-1.91
EBIT Margin
20.01%22.02%21.40%14.60%-32.61%
Effective Tax Rate
18.40%17.85%10.14%2.37%-
Revenue as Reported
337.16160.5651.9730.715.89
Source: S&P Global Market Intelligence. Standard template. Financial Sources.